• Tenecteplase vs Standard of Care for Minor Ischaemic Stroke with Proven Occlusion: The TEMPO-2 Trial

  • Sep 24 2024
  • Length: 22 mins
  • Podcast

Tenecteplase vs Standard of Care for Minor Ischaemic Stroke with Proven Occlusion: The TEMPO-2 Trial

  • Summary

  • ACCP EM PRN Journal Club: September 2024


    Presenter: Matthew Spinello, PharmD | PGY2 Emergency Medicine Pharmacy Resident | NewYork-Presbyterian Hospital


    Article presented: https://pubmed.ncbi.nlm.nih.gov/38768626/


    Copyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.


    Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.


    Produced by Christian Kroll, PharmD, BCPS

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Tenecteplase vs Standard of Care for Minor Ischaemic Stroke with Proven Occlusion: The TEMPO-2 Trial

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.